Unknown PHASE4 INTERVENTIONAL 2-arm NCT02291120

MEDCEM PC and MTA in Pulpotomies of Primary Molars

Sponsor: Universitat Internacional de Catalunya

Conditions Evaluate the Effects of MEDCEM PC and MTA in Pulpotomies of Primary Molars.

Interventions Pulpotomy

Updated 7 times since 2017 Last updated: Nov 11, 2014 Started: Mar 31, 2014 Primary completion: Oct 31, 2015 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02291120, this PHASE4 trial focuses on Evaluate the Effects of MEDCEM PC and MTA in Pulpotomies of Primary Molars. and remains ongoing. Sponsored by Universitat Internacional de Catalunya, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE4
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universitat Internacional de Catalunya

Data source: Universitat Internacional de Catalunya

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sant Cugat del Vallès, Spain